Stoneridge Investment Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-44,125
Closed -$223K 342
2015
Q4
$223K Buy
44,125
+6,000
+16% +$30.3K 0.03% 258
2015
Q3
$134K Hold
38,125
0.02% 270
2015
Q2
$380K Buy
+38,125
New +$380K 0.05% 228